Hasil Pencarian - Jin−Ji Yang

Perbaiki Hasil
  1. 1
    Mixed response to the first‐line treatment of KRAS G12C inhibitor, sotorasib, in non‐small cell lung cancer: A brief report

    Mixed response to the first‐line treatment of KRAS G12C inhibitor, sotorasib, in non‐small cell lung cancer: A brief report oleh Jiao Yang, Jie Huang, Gongjun Yuan, Xiao‐Cheng Lin, Hua‐Jun Chen, Jin‐Ji Yang

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Mutational landscape and characteristics of ERBB2 in non‐small cell lung cancer

    Mutational landscape and characteristics of ERBB2 in non‐small cell lung cancer oleh Xue‐Wu Wei, Xin Gao, Xu‐Chao Zhang, Jin‐Ji Yang, Zhi‐Hong Chen, Yi‐Long Wu, Qing Zhou

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Establishment of a Novel Method for Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance Mutations in Lung Cancer

    Establishment of a Novel Method for Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance Mutations in Lung Cancer oleh Hong-Xia Tian, Xu-Chao Zhang, Zhen Wang, Jin-Ji Yang, Wei-Bang Guo, Zhi-Hong Chen, Yi-Long Wu

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Molecular features and clinical outcomes of EGFR-mutated, MET-amplified non-small-cell lung cancer after resistance to dual-targeted therapy

    Molecular features and clinical outcomes of EGFR-mutated, MET-amplified non-small-cell lung cancer after resistance to dual-targeted therapy oleh Mei-Mei Fang, Jiang-Tao Cheng, Yu-Qing Chen, Xiao-Cheng Lin, Jun-Wei Su, Yi-Long Wu, Hua-Jun Chen, Jin-Ji Yang

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Genomic and Transcriptomic Analysis of Neuroendocrine Transformation in ALK-Rearranged Lung Adenocarcinoma After Treatments With Sequential ALK Inhibitors: A Brief Report

    Genomic and Transcriptomic Analysis of Neuroendocrine Transformation in ALK-Rearranged Lung Adenocarcinoma After Treatments With Sequential ALK Inhibitors: A Brief Report oleh Jie Huang, PhD, Shi-Ling Zhang, BD, Chaozheng Zhou, BD, Weiye Huang, MD, Peng Luo, BD, Hua-Jun Chen, PhD, Jin-Ji Yang, MD

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Genotyping of RB1 status identifies two distinct subtypes in EGFR‐mutant lung cancers with SCLC transformation

    Genotyping of RB1 status identifies two distinct subtypes in EGFR‐mutant lung cancers with SCLC transformation oleh Jie Huang, Shi‐Ling Zhang, Chao Zhang, Weiye Huang, Zhenhua Zhang, Yu‐Qing Chen, Jun‐Wei Su, Hong‐Hong Yan, Hua‐Jun Chen, Jin‐Ji Yang, Junjian Wang, Yi‐Long Wu

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Prediction of unfavourable response to checkpoint blockade in lung cancer patients through an integrated tumour-immune expression score

    Prediction of unfavourable response to checkpoint blockade in lung cancer patients through an integrated tumour-immune expression score oleh Si-Yang Maggie Liu, Hao Sun, Jia-Ying Zhou, Jia-Tao Zhang, Kai Yin, Zhi-Hong Chen, Jian Su, Xu-Chao Zhang, Jin-Ji Yang, Qing Zhou, Hai-Yan Tu, Yi-Long Wu

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients

    Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients oleh Si-Yang Liu, Hao Sun, Jia-Ying Zhou, Guang-Ling Jie, Zhi Xie, Yang Shao, Xian Zhang, Jun-Yi Ye, Chun-Xiang Chen, Xu-Chao Zhang, Qing Zhou, Jin-Ji Yang, Yi-Long Wu

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial

    Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial oleh Qing Zhou, Jin-Ji Yang, Zhi-Hong Chen, Xu-Chao Zhang, Hong-Hong Yan, Chong-Rui Xu, Jian Su, Hua-Jun Chen, Hai-Yan Tu, Wen-Zhao Zhong, Xue-Ning Yang, Yi-Long Wu

    Diterbitkan 2016-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Different dissecting orders of the pulmonary bronchus and vessels during right upper lobectomy are associated with surgical feasibility and postoperative recovery for lung cancer patients

    Different dissecting orders of the pulmonary bronchus and vessels during right upper lobectomy are associated with surgical feasibility and postoperative recovery for lung cancer p... oleh Hao-Ran Zhai, Xue-Ning Yang, Qiang Nie, Ri-Qiang Liao, Song Dong, Wei Li, Ben-Yuan Jiang, Jin-Ji Yang, Qing Zhou, Hai-Yan Tu, Xu-Chao Zhang, Yi-Long Wu, Wen-Zhao Zhong

    Diterbitkan 2017-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status.

    Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status. oleh She-Juan An, Zhi-Hong Chen, Jian Su, Xu-Chao Zhang, Wen-Zhao Zhong, Jin-Ji Yang, Qing Zhou, Xue-Ning Yang, Ling Huang, Ji-Lin Guan, Qiang Nie, Hong-Hong Yan, Tony S Mok, Yi-Long Wu

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangement

    Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangement oleh Qing-Yun Gao, Fa-Man Xiao, Xiao-Cheng Lin, Yu-Qing Chen, Yu-Fa Li, Chang Lu, Jun-Wei Su, Quan-Quan Tan, Chan-Yuan Zhang, Jiao Yang, Yi-Long Wu, Hua-Jun Chen, Jin-Ji Yang

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Plasma ddPCR for the detection of amplification in advanced NSCLC patients: a comparative real-world study

    Plasma ddPCR for the detection of amplification in advanced NSCLC patients: a comparative real-world study oleh Jun-Wei Su, Cheng-Di Weng, Xiao-Cheng Lin, Mei-Mei Fang, Xiao Xiao, Yi-Chen Zhang, Xu-Chao Zhang, Jian Su, Chong-Rui Xu, Hong-Hong Yan, Hua-Jun Chen, Yi-Long Wu, Jin-Ji Yang

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patients

    The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patients oleh Yu-Qing Chen, Ling-Ling Gao, Ling-Cong Kong, Xu-Hui Guan, Huan Yang, Yu-Fa Li, Zhi-Yi Lv, Xu-Chao Zhang, Hui-Ying Liang, Hua-Jun Chen, Yi-Long Wu, Jie Huang, Jin-Ji Yang

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Concomitant genetic alterations having greater impact on the clinical benefit of EGFR‐TKIs in EGFR‐mutant advanced NSCLC than BIM deletion polymorphism

    Concomitant genetic alterations having greater impact on the clinical benefit of EGFR‐TKIs in EGFR‐mutant advanced NSCLC than BIM deletion polymorphism oleh Si‐Yang Liu, Jia‐Ying Zhou, Wen‐Feng Li, Hao Sun, Yi‐Chen Zhang, Hong‐Hong Yan, Zhi‐Hong Chen, Chun‐Xiang Chen, Jun‐Yi Ye, Jin‐Ji Yang, Qing Zhou, Xu‐Chao Zhang, Yi‐Long Wu

    Diterbitkan 2020-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases

    Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases oleh Mei-Mei Zheng, Yang-Si Li, Hai-Yan Tu, Hao Sun, Kai Yin, Ben-Yuan Jiang, Jin-Ji Yang, Xu-Chao Zhang, Qing Zhou, Chong-Rui Xu, Zhen Wang, Hua-Jun Chen, De-Xiang Zhou, Yi-Long Wu

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

    Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression oleh Rui-Lian Chen, Jun Zhao, Xu-Chao Zhang, Na-Na Lou, Hua-Jun Chen, Xue Yang, Jian Su, Zhi Xie, Qing Zhou, Hai-Yan Tu, Wen-Zhao Zhong, Hong-Hong Yan, Wei-Bang Guo, Yi-Long Wu, Jin-Ji Yang

    Diterbitkan 2018-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients

    Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients oleh Zhen Wang, Xu-Chao Zhang, Wei-Neng Feng, Li Zhang, Xiao-Qing Liu, Wei-Bang Guo, Yan-Ming Deng, Qing-Feng Zou, Jin-Ji Yang, Qing Zhou, Bin-Chao Wang, Hua-Jun Chen, Hai-Yan Tu, Hong-Hong Yan, Yi-Long Wu

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the EGFR L858R Mutation: A Brief Report

    Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the EGFR L858R Mutation: A Brief Report oleh Yu-Qing Chen, BD, Yu-Fa Li, MD, Chan-Yuan Zhang, MD, Shi-Ling Zhang, BD, Zhi-Yi Lv, PhD, Song Dong, PhD, Hua-Jun Chen, PhD, Xu-Chao Zhang, PhD, Yi-Long Wu, MD, Jin-Ji Yang, MD

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors

    MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors oleh Lun-Xi Peng, Guang-Ling Jie, An-Na Li, Si-Yang Liu, Hao Sun, Mei-Mei Zheng, Jia-Ying Zhou, Jia-Tao Zhang, Xu-Chao Zhang, Qing Zhou, Wen-Zhao Zhong, Jin-Ji Yang, Hai-Yan Tu, Jian Su, Hong-Hong Yan, Yi-Long Wu

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: